144 related articles for article (PubMed ID: 12694227)
1. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma.
Yamaguchi S; Yoshihiro S; Matsuyama H; Nagao K; Fukunaga K; Matsumoto H; Matsuda K; Oba K; Naito K
Clin Genet; 2003 Mar; 63(3):184-91. PubMed ID: 12694227
[TBL] [Abstract][Full Text] [Related]
2. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.
Sato K; Qian J; Slezak JM; Lieber MM; Bostwick DG; Bergstralh EJ; Jenkins RB
J Natl Cancer Inst; 1999 Sep; 91(18):1574-80. PubMed ID: 10491435
[TBL] [Abstract][Full Text] [Related]
4. Allelic loss of 3p25 associated with alterations of 5q22.3 approximately q23.2 may affect the prognosis of conventional renal cell carcinoma.
Nagao K; Yamaguchi S; Matsuyama H; Korenaga Y; Hirata H; Yoshihiro S; Fukunaga K; Oba K; Naito K
Cancer Genet Cytogenet; 2005 Jul; 160(1):43-8. PubMed ID: 15949569
[TBL] [Abstract][Full Text] [Related]
5. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients.
Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK
Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757
[TBL] [Abstract][Full Text] [Related]
6. Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer.
Kurimoto F; Gemma A; Hosoya Y; Seike M; Takenaka K; Uematsu K; Yoshimura A; Shibuya M; Kudoh S
Int J Mol Med; 2001 Jul; 8(1):89-93. PubMed ID: 11408955
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.
Moch H; Schraml P; Bubendorf L; Richter J; Gasser TC; Mihatsch MJ; Sauter G
Cancer Res; 1998 Jun; 58(11):2304-9. PubMed ID: 9622063
[TBL] [Abstract][Full Text] [Related]
8. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
9. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer.
Oba K; Matsuyama H; Yoshihiro S; Kishi F; Takahashi M; Tsukamoto M; Kinjo M; Sagiyama K; Naito K
Cancer Genet Cytogenet; 2001 Jan; 124(1):20-6. PubMed ID: 11165318
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
11. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
[TBL] [Abstract][Full Text] [Related]
12. Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas.
Chudek J; Wilhelm M; Bugert P; Herbers J; Kovacs G
Int J Cancer; 1997 Oct; 73(2):225-9. PubMed ID: 9335447
[TBL] [Abstract][Full Text] [Related]
13. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.
Wistuba II; Behrens C; Virmani AK; Milchgrub S; Syed S; Lam S; Mackay B; Minna JD; Gazdar AF
Cancer Res; 1999 Apr; 59(8):1973-9. PubMed ID: 10213509
[TBL] [Abstract][Full Text] [Related]
16. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.
Corless CL; Aburatani H; Fletcher JA; Housman DE; Amin MB; Weinberg DS
Diagn Mol Pathol; 1996 Mar; 5(1):53-64. PubMed ID: 8919546
[TBL] [Abstract][Full Text] [Related]
17. 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival.
Eichenauer T; Bannenberg DC; Kluth M; Wittmer C; Büscheck F; Möller K; Dum D; Fraune C; Hube-Magg C; Möller-Koop C; Dahlem R; Fisch M; Rink M; Riechardt S; Tsourlakis MC; Bernreuther C; Minner S; Simon R; Sauter G; Wilczak W; Clauditz TS
Urol Oncol; 2020 Feb; 38(2):43.e13-43.e20. PubMed ID: 31757738
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
19. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F
Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
